Revenue segments as reported by the company.

Online Revenue

Wholesale Revenue

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing

Operations and support

Technology and development

Selling, general, and administrative

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Hims & Hers Health

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

HIMS & Hers reports robust Q1 earnings, eyes new growth opportunities

HIMS & Hers reported impressive financial performance, driven by strong revenue growth and a growing subscriber base. The company's strategic pillars and partnerships with celebrities are contributing to its success. However, increased investment and the decision on insurance reimbursement pose challenges, while opportunities lie in expanding awareness, personalized products, and potential entry into new therapeutic categories.

HIMS & Hers Health reports robust Q2 growth and addresses product challenges

HIMS & Hers Health's Q2 2023 performance showcased significant revenue growth and subscriber momentum. The company is focused on personalized treatments, new category launches, and omnichannel marketing. However, challenges related to reimbursement rates, product confidence, and repricing initiatives are being addressed, while opportunities in efficiency gains, subscription offerings, and AI applications are being pursued.

HIMS & Hers Health reports exceptional Q3 performance and optimistic outlook for 2024

HIMS & Hers Health's Q3 results demonstrate strong growth and strategic initiatives, while facing challenges in pricing and gross margin management. The company is optimistic about future performance, driven by personalized product adoption and efficiency gains.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Hims was founded in November 2017 after Andrew Dudum was called out by his sister for having dry skin and breakouts. After she ordered him expensive products to address his issues, Dudum realized that men don't have the same options as women when it comes to purchasing wellness products. 

Now with radiant skin, Andrew Dudum and Jack Abraham co-found HIMS as an Atomic (VC fund) portfolio company. The company initially sells hair loss treatments, biotin vitamins, shampoo, and erectile dysfunction treatments. 

The company raises $7 million in Series A from M/C Partners, SV Angel and Thrive Captial, putting its pre-money valuation at $13 million.

Hims raises $40 million in Series B led by IVP and Redpoint Ventures, putting its pre-money valuation at $160 million. 

Hims launches a women's brand, Hers. 

Hers offers telemedicine services, birth control, and non-prescription hair and skin-care products. 

The company partners with A-list couple Jennifer Lopez and Alex Rodriguez, who work with the company on the launch of new products. 

Hims raises $297 million in Series C funding led by DCM Ventures, NewView Capital, McKesson Ventures, putting its valuation at $1 billion.

Hims and Hers expands into virtual mental health services led by licensed professionals, with support groups available free of charge during the COVID-19 pandemic. 

The company now provides access to medical care and treatment for more than a dozen conditions with more than 50 products, and has facilitated 1 million medical visits through its telehealth platforms in 2019. 

Hims goes public through a merger with a blank-check company Oaktree Acquisition Corp at $1.6 billion valuation.

forhims.com/aboutus
forhims.com/investors
SEC
CNBC
Business Insider
Bloomberg
Crunchbase
Axios

The shares of Hims & Hers Health Inc (NYSE: HIMS) have received a price target of $12 from Piper Sandler. These are the details.

Hims & Hers Health (HIMS) Stock: $12 Price Target From Piper Sandler

Hims & Hers recently reported a strong fiscal 2021 third quarter which saw a beat on analyst consensus. The company also revised its revenue guidance for fiscal 2021 upwards.

Hims & Hers: Eventually The Ugly Duckling Becomes A Beautiful Swan

Hims & Hers Health, Inc. (HIMS) CEO Andrew Dudum on Q3 2021 Results - Earnings Call Transcript

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers unveiled its plans to provide more complete, holistic and personalized care experiences with the launch of the Hims & Hers mobile app.

Hims & Hers Unveils Mobile Platform For Their Over 500,000 Subscription Members

SAN FRANCISCO--(BUSINESS WIRE)---- $HIMS--Hims & Hers Health, Inc. Reports Third Quarter 2021 Financial Results; Q3 2021 revenue grows 79% year-over-year to $74.2 million

Hims & Hers Health, Inc. Reports Third Quarter 2021 Financial Results

Novavax

Invitae

Analyst price targets for three top growth stocks suggest big gains just up ahead.

3 Stocks That Could Soar 46% or More, According to Wall Street

SAN FRANCISCO--(BUSINESS WIRE)---- $HIMS--Hims & Hers Health, Inc. (NYSE:HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, announced today that CEO Andrew Dudum and Chief Medical Officer Patrick Carroll will participate in the Credit Suisse 30th Annual Healthcare Conference with one-on-one meetings throughout the day on Thursday, November 11, 2021. A fireside chat presentation with Chief Executive Officer Andrew Dudum

Hims & Hers Health, Inc. to Participate at Credit Suisse 30th Annual Healthcare Conference

Walgreens

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers collaborates with Walgreens to offer a range of the company's solutions at Walgreens retail locations nationwide and on walgreens.com.

Hims & Hers and Walgreens Collaborate to Expand Availability of Personal Care Offerings to 7,000+ Stores and Online Nationwide

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers introduced Climax Delay Wipes as a new non-prescription offering within Hims' Sexual Health category on forhims.com.

Hims & Hers Expands Support for Men's Sexual Wellness With Introduction of Climax Delay Wipes

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, will release fiscal third quarter financial results on Wednesday, November 10, 2021 after market close, with a conference call to follow at 5:00 p.m. E.T. Conference Call Details The conference call can be accessed by dialing (833) 900-2256 for U.S. participants and (236) 714-2

Hims & Hers Health, Inc. to Announce Third Quarter 2021 Financial Results and Host Conference Call

Investors are skeptical of Hims & Hers, pushing the stock back toward 52-week lows during September's sell-off. But are they right?

This Under-the-Radar Healthcare Stock Might Be on Sale for the Last Time

Wellness and telehealth company Hims & Hers Health Inc. HIMS, +2.03% said Monday that its haircare products will now be available at 280 Vitamin Shoppe locations and on the retailer's website. Vitamin Shoppe is a subsidiary of Franchise Group Inc. FRG, -1.36%.

Hims & Hers hair products now available at Vitamin Shoppe locations

Hims & Hers Health Inc (NYSE: HIMS) has partnered with The Vitamin Shoppe , a subsidiary of Franchise Group Inc (NASDAQ: FRG), to make its products available on the latter's platform. The financial terms of the arrangement remain undisclosed.

Vitamin Shoppe To Offer Haircare Products From Hims & Hers

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Inc. announced that their haircare products are now available both online and in-store at over 280 locations of The Vitamin Shoppe.

Hims & Hers Partners with The Vitamin Shoppe To Expand Availability Of Personal Care Offerings To Over 280 Stores and Online Across the U.S.

Hims & Hers is back to reporting impressive revenue growth near 70%.

Hims & Hers: Subscription Health Re-Evaluated

As high-growth names start to make a comeback, investors would do well to consider this healthcare stock. Hims is likely to smash through its 30% revenue growth rate expectations in 2022.

Hims & Hers Health: An Amazing Bargain Price For This High Growth Stock

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers, a multi-specialty telehealth platform, recently launched Hims Overnight Anti-Aging Duo and a customized Hers Clear Skin System.

Hims & Hers Expands Customizable, Compounded Skincare Offerings With Hims Overnight Anti-Aging Duo, Hers Clear Skin System

Hims & Hers Health Inc (NYSE: HIMS) has expanded its women's health offerings by launching a D-Mannose dietary supplement powder to support urinary tract health on ForHers.com. The supplement powder comes in packages of 10 cranberry-raspberry flavored single-serve packets.

Hims & Hers Launches Supplement Powder To Support Urinary Tract Health

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers recently expanded its women's health offerings with the launch of a D-Mannose dietary supplement powder to support urinary tract health.

Hims & Hers Expands Women's Health Offerings With Support For Urinary Tract Health

Revolve

Hims & Hers Health Inc. HIMS, +1.04% said Wednesday that its products focused on skin and haircare, sleep and sexual health will now be available on the e-commerce fashion site Revolve. Revolve Group Inc. RVLV, +1.47% targets millennials and Gen Z.

E-commerce fashion site Revolve adds health products from Hims & Hers

Telehealth platform Hims & Hers Health Inc (NYSE: HIMS) has announced a partnership with Revolve Group Inc (NYSE: RVLV). Revolve will add a range of health and wellness solutions from Hims & Hers to its site, Revolve.com.

Revolve To Offer Hims & Hers Health Products

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers partners with REVOLVE to offer diverse range of health and wellness solutions on its site, REVOLVE.com.

Hims & Hers Partners with REVOLVE to Help More Consumers Access High Quality, Personalized Health and Wellness Solutions

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE:HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, announced today that its management team will participate at two upcoming conferences: Citi's 2021 Virtual Global Technology Conference, taking place Monday, September 13th – Wednesday, September 15th with one-on-one investor meetings throughout the day on September 14th. Raymon

Hims & Hers Health to Present at Upcoming Financial Conferences

Inari Medical

Renalytix AI plc

All three are rapidly expanding into their own corners of America's $4 trillion per year healthcare sector.

3 High-Growth Healthcare Stocks to Buy in September

Zoom Video

Both grew their sales by more than 50% in their most recent quarters.

News for Hims & Hers Health Stock (HIMS)